![Matthew Greenhawt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermögen: 393 470 $ am 31.08.2026
Mr. Matthew Greenhawt was previously employed as a Chief Medical Officer by Aquestive Therapeutics, Inc. and a Chief Medical Officer by Asthma & Allergy Foundation of America.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 09.03.2026 | 77’000 ( 0.06% ) | 393 470 $ | 31.08.2026 |
| Unternehmen | Position | Ende |
|---|---|---|
Asthma & Allergy Foundation of America
 Asthma & Allergy Foundation of America Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2026 |
| AQUESTIVE THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 2 |
|---|---|
Aquestive Therapeutics, Inc.
 Aquestive Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops & commercializes thin film pharmaceutical and over the counter drug products | Health Technology |
Asthma & Allergy Foundation of America
Asthma & Allergy Foundation of America Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
